$ Hyphens Pharma (1J5:SGX)
$0.325 0.0 (0.0%)
Analysed $ Hyphens Pharma (1J5:SGX) News Sources
Is Hyphens Pharma International Limited's (Catalist:1J5) Recent Stock Performance Tethered To Its Strong Fundamentals?
18-06-2025
yahoo.com
Cosmo Announces Launch of Winlevi(R) for Treatment of Acne in Singapore and Malaysia
17-07-2025
yahoo.com
Hyphens Pharma International Reports First Half 2025 Earnings
14-08-2025
yahoo.com
These Analysts Think Hyphens Pharma International Limited's (Catalist:1J5) Sales Are Under Threat
29-08-2025
yahoo.com
Investing in Hyphens Pharma International (Catalist:1J5) three years ago would have delivered you a 65% gain
09-10-2025
yahoo.com
Hyphens Pharma International Limited's (Catalist:1J5) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
26-11-2025
yahoo.com
Hyphens Pharma out‑licences Cerapro® MED Skin Barrier Cream for six European countries
05-01-2026
yahoo.com
Hyphens Pharma International's (Catalist:1J5) Soft Earnings Are Actually Better Than They Appear
16-04-2026
yahoo.com
Executive Chairman & CEO of Hyphens Pharma International See Wah Lim Buys 650% More Shares
24-04-2026
yahoo.com
What is the current price of $ Hyphens Pharma (1J5:SGX)?
The current price of $ Hyphens Pharma (1J5:SGX) is $0.325.
$ Hyphens Pharma (1J5:SGX) absolute price change since previous trading day?
The absolute price change of $ Hyphens Pharma (1J5:SGX) since the previous trading day is $0.0.
$ Hyphens Pharma (1J5:SGX) percentage price change since previous trading day?
The percentage price change of $ Hyphens Pharma (1J5:SGX) since the previous trading day is 0.0%.
What is the most recent average sentiment score for $ Hyphens Pharma (1J5:SGX)?
The most recent average sentiment score for $ Hyphens Pharma (1J5:SGX) is 58 out of 100.
What is the most recent average sentiment for $ Hyphens Pharma (1J5:SGX)?
The most recent sentiment for $ Hyphens Pharma (1J5:SGX) is .
SEC-8K** Filing Unavailable For $ Hyphens Pharma (1J5:SGX)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.